Previous Close | 13.13 |
Open | 13.14 |
Bid | 13.34 x 1500 |
Ask | 13.41 x 500 |
Day's Range | 13.13 - 13.49 |
52 Week Range | 9.08 - 13.62 |
Volume | |
Avg. Volume | 7,705,403 |
Market Cap | 15.958B |
Beta (5Y Monthly) | 0.93 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.73 |
Earnings Date | Nov 07, 2024 |
Forward Dividend & Yield | 0.48 (3.59%) |
Ex-Dividend Date | Nov 22, 2024 |
1y Target Est | 13.08 |
U.S. pharmaceutical giant Viatris Inc has been fined 7.58 million dirhams ($760,000) by Morocco's competition regulator for failing to notify it regarding its merger, two official sources said on Thursday. Viatris was formed by the merger of Mylan, which has a subsidiary in Morocco, and Pfizer's Upjohn business in 2020. The fine, equivalent to 2.5% Viatris' revenue in Morocco last year, has already been paid to the Moroccan treasury, the sources said, requesting anonymity.
TBPH beats third-quarter estimates for both sales and earnings. Increased collaboration revenues from Viatris drive year-over-year top-line performance.